Latest News

Cochlear's (ASX:COH) stock is up by 9.9% over the past three months. Given its impressive performance, we decided to...

Readers hoping to buy Briscoe Group Limited ( NZSE:BGP ) for its dividend will need to make their move shortly, as the...

It looks like Port of Tauranga Limited ( NZSE:POT ) is about to go ex-dividend in the next four days. The ex-dividend...

Analyst reports in September 2025 highlighted Mercury General as a strong value stock, with a Zacks Rank #1 (Strong Buy) and an A grade in value, reflecting renewed investor interest due to favorable valuation metrics and positive earnings outlook. An interesting development is that, despite strong analyst sentiment, Mercury General’s return on equity remains below industry averages, leading some analysts to recommend exploring alternative growth options. We'll explore how increased analyst...

If you have been following 4DMedical (ASX:4DX), you know the company’s latest run of partnership announcements is catching attention across the market, especially for those weighing their next move in the stock. Over just a few weeks, 4DMedical has inked multi-year deals supporting Australia’s National Lung Cancer Screening Program, launched an initiative in Brazil with a key pharma partner, and rolled out a hospital pilot with Royal Melbourne Hospital. Coming soon after US regulatory wins,...

Over the past month, Backblaze, Inc. (NASDAQ:BLZE) saw its shares advance strongly, even though analysts project its revenue will grow at a slower pace than the broader IT industry. This disconnect between market enthusiasm and modest growth expectations has drawn attention to whether the company's valuation can be supported by its current fundamentals. We’ll explore how the surge in Backblaze’s share price, despite its subdued revenue outlook, may affect its overall investment...

For those following Mitsubishi Logistics (TSE:9301), any move in the stock can prompt investors to pause and wonder if something bigger is brewing under the surface, or whether today’s price simply reflects market mechanics as usual. With no single headline to pin the action on, this low-key shift may seem routine. Yet, it still draws attention to underlying questions about the company's trajectory and what investors are truly buying here. Over the past year, Mitsubishi Logistics shares have...

Sumitomo DensetsuLtd (TSE:1949) might not make headlines every week, but this recent move in its stock is making some investors sit up and take notice. With the shares showing new momentum, it is natural to wonder what is driving the action and whether there is more to come. The company has steadily grown revenue and net income over the past year, signaling a stable and measured pace for the underlying business. Looking at the bigger picture, Sumitomo DensetsuLtd’s stock price has seen major...

If you have been watching Hour Loop (HOUR), the stock's recent run-up might have caught your eye. Shares have soared an eye-opening 59% in recent trading, with investors responding enthusiastically to the company’s jump in earnings per share. What stands out is not just the earnings, but the fact that growth came despite a slight dip in revenue and fresh challenges from new U.S. trade measures aimed at Chinese imports. Hour Loop’s leadership is crediting the surprising gains to tighter cost...

Option Care Health recently reported second-quarter 2025 earnings that exceeded expectations, marked by 15% year-over-year revenue growth and strong management signals, including a director acquiring 3,411 shares of company stock and the appointment of Meenal A. Sethna as Executive Vice President and CFO, effective October 1, 2025. This combination of robust financial performance and leadership changes points to management's optimism about the company's future direction and growth...

If you follow Alfresa Holdings (TSE:2784), you might have noticed its recent share price action catching a few extra glances this month. There is no headline-grabbing news event or big announcement moving the needle, but it is often just these quieter periods that give investors the best clues about how the market is weighing up a company’s prospects. Sometimes, a lack of bombshells is a story in itself, especially if a stock starts to drift or gain momentum when no obvious catalysts are at...

If you have ever wondered whether now is the right time to buy, hold, or reconsider Regeneron Pharmaceuticals, you are definitely not alone. The company has been on quite a ride, with shares recently closing at $560. Quick glances at the stock chart show a stark contrast between short-term and long-term moves, with the price down 2.3% over the past week, and only slightly lower at 0.3% for the last month. However, the picture becomes far more dramatic if you zoom out: year to date,...

Meitav Investment House (TASE:MTAV) has caught the attention of investors yet again, as recent trading activity prompts a closer look at what might be driving sentiment around the stock. While there has not been any single headline-grabbing event, the latest moves could be signaling a shift in perceptions about the company’s growth prospects. For anyone considering whether to hold tight, buy, or wait on the sidelines, it is the perfect time to revisit what is really happening beneath the...

QUALCOMM (QCOM) just gave investors something new to ponder with the appointment of Dr. Jeremy Kolter to its Board of Directors. Dr. Kolter brings an impressive mix of academic leadership and industry experience, most recently as Professor and Department Head of Machine Learning at Carnegie Mellon University, as well as a role on OpenAI’s board overseeing AI safety. This move puts a spotlight on QUALCOMM’s intent to double down on AI safety, robustness, and optimization, areas quickly...

In the past week, Veritone completed a US$25 million follow-on equity offering and presented at the H.C. Wainwright Global Investment Conference, showcasing its AI-driven solutions for government and law enforcement sectors as well as a promising Veritone Data Refinery pipeline. An interesting insight is Veritone's focus on securing direct government contracts and progressing toward a pure AI-centric model, supported by validation from early proof-of-concept contracts with agencies such as...

RBC Bearings recently elected Barry C. Boyan as a new director during its September 4, 2025 annual meeting and presented at two major industry conferences, with executive leadership discussing the company's outlook. This series of events signals a continued focus on leadership renewal and increased industry engagement as RBC Bearings experiences heightened demand in its aerospace and defense business lines. Next, we'll examine how the surge in aerospace and defense orders may impact RBC...

Virtu Financial (VIRT) is catching the eye of investors this week after receiving a 'Strong Buy' rating and an 'A' grade in the Value category from Zacks. At a time when many are hunting for value plays in the market, Virtu is standing out for its attractive valuation metrics and favorable earnings outlook. The recent spotlight on its price-to-earnings, price-to-sales, and related ratios has increased interest among those looking for growth at a reasonable price. The stock's performance...

In recent days, LGI Homes faced cautious analyst sentiment as Wedbush reiterated a "neutral" rating and JPMorgan Chase & Co. issued an "underweight" rating, both following a significant year-over-year revenue decline in the company’s latest quarterly report. This analyst response highlights how current shifts in the national housing market are weighing on homebuilders with a primary focus on affordable entry-level homes. We'll examine how analyst downgrades tied to LGI Homes' recent revenue...

Blink Charging Co. recently regained compliance with Nasdaq’s minimum bid price rule and officially joined the Paua platform, a leading UK EV charging aggregator, expanding its network by 850 locations and 3,500 connectors. This collaboration provides Paua customers with immediate access to Blink chargers across the UK, reflecting Blink's continued push for global accessibility and infrastructure integration in the electric vehicle charging market. We'll examine how Blink's expanded UK...

A planned leadership change is always worth a closer look, and Lundin Gold (TSX:LUG) has certainly grabbed investor attention with the announcement that Jamie Beck, former CEO of Filo Corp., will take over as President and CEO this November. Beck’s reputation for driving value within the Lundin Group, paired with his operational and exploration background, makes this a significant moment for the company’s future direction. After a decade under Ron Hochstein’s stewardship, investors are now...

A10 Networks (ATEN) just announced that Brian Becker, its Chief Financial Officer, will be stepping down at the end of September. The company’s next CFO, Michelle Caron, brings over 20 years of finance experience. She most recently served as VP Finance and CFO at Beckman Coulter Lifesciences, a division of Danaher. Leadership changes at the CFO level often get investor attention, since this role sits at the heart of strategy, financial health, and execution. If you have been watching A10...

Encompass Health (EHC) just opened the doors to a brand-new 50-bed inpatient rehabilitation hospital in The Villages, Central Florida, and it is already welcoming its first patients. This move stands out as a meaningful expansion for the company and is designed to address surging demand for intensive rehabilitation services in one of the country’s fastest-growing retirement communities. Advanced therapy technology and personalized care at this facility serve as important additions not only...

Miura (TSE:6005) has quietly moved onto the radar for investors after recent trading activity sparked a fresh round of questions about its long-term direction. There’s no headline-making event or blockbuster announcement this week, but the steady movement in Miura’s share price might have some market watchers wondering if this is just noise or a signal. For anyone weighing whether Miura is worth a closer look now, the backdrop remains particularly interesting. Over the past year, Miura’s...

If you’ve been watching Amicus Therapeutics (FOLD) lately, you probably noticed the buzz after their recent data release. The company just unveiled fresh 4-year efficacy and safety results from its PROPEL open-label extension study, focused on cipaglucosidase alfa-atga plus miglustat for adults dealing with late-onset Pompe disease. Presented at a major medical conference, these updated findings offer a longer-term look at muscle function and patient outcomes, putting Amicus back on the radar...